http://www.mmm-online.com/deborah-weinstein/author/1215/ Latest articles by Deborah Weinstein from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world. http://www.mmm-online.com/mayo-device-helps-monitor-heart-patients-from-afar/article/294386/ Wed, 22 May 2013 14:59:55 GMT Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world. MMM The actor and patient heads up a roundtable posted on the advocacy site CreakyJoints. http://www.mmm-online.com/belushi-savient-observe-gout-awareness-day/article/294381/ Wed, 22 May 2013 14:51:10 GMT The actor and patient heads up a roundtable posted on the advocacy site CreakyJoints. MMM The company's latest outreach, an Auvi-Q promotion, breaks down allergy management into sports playbook presentation. http://www.mmm-online.com/ex-nfler-sanofi-talk-anaphylaxis/article/294018/ Mon, 20 May 2013 14:58:33 GMT The company's latest outreach, an Auvi-Q promotion, breaks down allergy management into sports playbook presentation. MMM Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March. http://www.mmm-online.com/purdue-puts-intermezzo-dtc-to-bed/article/293546/ Thu, 16 May 2013 20:36:00 GMT Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March. MMM The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer. http://www.mmm-online.com/fda-gut-checks-dtc-clarity/article/293327/ Tue, 14 May 2013 17:50:23 GMT The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer. MMM Generic Opana ER got the go-ahead from FDA, exposing the drugmaker to generic competition -- unlike Purdue, whose tamper-proof painkiller won standalone status. http://www.mmm-online.com/fda-move-gives-purdue-edge-in-painkiller-market/article/293166/ Mon, 13 May 2013 17:25:56 GMT Generic Opana ER got the go-ahead from FDA, exposing the drugmaker to generic competition -- unlike Purdue, whose tamper-proof painkiller won standalone status. MMM The FDA approved the Breo/Ellipta combo, but analysts are wary about its potential to go beyond the COPD indication in the US. http://www.mmm-online.com/gsk-adds-competitor-to-copd-market/article/292934/ Fri, 10 May 2013 20:43:31 GMT The FDA approved the Breo/Ellipta combo, but analysts are wary about its potential to go beyond the COPD indication in the US. MMM Already the world's third-largest generics maker, Actavis stands to gain if it can seal the deal http://www.mmm-online.com/actavis-may-buy-warner-chilcott/article/292931/ Fri, 10 May 2013 20:23:42 GMT Already the world's third-largest generics maker, Actavis stands to gain if it can seal the deal MMM Quarterly reports show that that the weight loss category remains a cool one, but studies indicate that even the best marketing plan will have to overcome payer and pricing issues. http://www.mmm-online.com/orexigen-vivus-remain-in-weight-loss-limbo/article/292704/ Thu, 09 May 2013 18:03:25 GMT Quarterly reports show that that the weight loss category remains a cool one, but studies indicate that even the best marketing plan will have to overcome payer and pricing issues. MMM Two studies released show that the story behind lower consumer healthspend isn't about generics improving health. http://www.mmm-online.com/studies-show-cheaper-drugs-dont-add-up-to-greater-use/article/292626/ Thu, 09 May 2013 16:09:46 GMT Two studies released show that the story behind lower consumer healthspend isn't about generics improving health. MMM